• Tidak ada hasil yang ditemukan

Perbedaan Kadar Hba1c Pada Penderita Diabetes Mellitus Type 2 Dengan Dan Tanpa Stroke Iskemik

N/A
N/A
Protected

Academic year: 2017

Membagikan "Perbedaan Kadar Hba1c Pada Penderita Diabetes Mellitus Type 2 Dengan Dan Tanpa Stroke Iskemik"

Copied!
10
0
0

Teks penuh

(1)

55 DAFTAR PUSTAKA

1. Gavin JR, Alberti KGMM, Davidson MB, DeFronzo RA, Drash A, Gabbe SG. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2001; 24 (Suppl.1): S5-S20.

2. Sacks DB, Arnold M, Bakris GL et al. Position statement executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care. 2011;341419–1423.

3. Truelsen, T. Begg, S. Mathers, C. The Global Burden of Cerebrovascular Disease. 2000. Burden of Diseases. World Health Organization. 2000.

4. Mansjoer, A., Suprohaita, S.W., Dkk. 2000,.Stroke. Kapita Selekta Kedokteran, Edisi ketiga jilid 2, Media Aesculapius Fakultas Kedokteran UI: Jakarta,17.

5. International Diabetes Federation. Diabetes Atlas. 6th ed. Brussels (Belgium): International Diabetes Federation; 2013

(2)

56 7. Perkumpulan Endokrinologi Indonesia. Konsensus Pengendalian dan

Pencegahan Diabetes Mellitus Tipe2 di Indonesia 2011, PB. PERKENI. Jakarta 2011

8. Hinkle, JL. Guanci, MM. Acute Ischemic Stroke Review. J Neurosci Nurs. 2007; 39 (5): 285-293, 310

9. Maas, MB. Safdieh, JE. Ischemic Stroke: Pathophysiology and Principles of Localization. Neurology Board Review Manual. Neurology. 2009; 13(1): 2-16

10. Sutrisno, Alfred. Stroke? You Must Know Before you Get It!. Jakarta: PT. Gramedia Pustaka Utama. 2007. Hal: 1-13

11. Departemen Kesehatan. Pusat Data dan Informasi. Profil Kesehatan Indonesia 2008. Jakarta. Departemen Kesehatan RI 2009

12. Widjaja D. Perkembangan penyelidikan mutakhir faktor risiko stroke. Kumpulan Makalah Simposium Continuing Medical Education (CME). The VIth Perdossi Course on Stroke 1999:1-25.

13. Megherbi SE, Milan C, Minier D, et al. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. Stroke 2003;34:688-94.

(3)

57 15. Sander D, Sander K, Poppert H. Review : Stroke in type 2 diabetes.

British Journal of Diabetes & Vascular Disease 2008: 8: 222

16. Boden-Albala B, Sacco RL, Lee HS et al. Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study. Stroke 2008; 39:30-5 17. Ravipati G, Aronow WS, Kumbar S. Patients with diabetes mellitus with

ischemic stroke have a higher hemoglobin A1c level and a higher serum lowdensity lipoprotein cholesterol level than diabetics without ischemic stroke. Arch Med Sci 2009; 5, 3: 391-393

18. Warlow CP, Dennis MS, vanGijn J, Hankey GJ, Sandercock PAG, Bamford JM, et al. Stroke a practical guide to management. Oxford: Blackwell Science; 1996.

19. Davis SM. New information about managing temperature, blood pressure and glucose in acute ischemic stroke. Ann Am Neurol 2000; 2: 1-12.

20. Oppenheimer SM, Hoffbrand BI, Oswald GA, Yudkin J. Diabetes mellitus and early mortality from stroke. Br Med J 1985; 291: 1014-5. 21. Bener, A., Kamran, S., Elouzi, E.B., Hamad, A., Heller, R.F.

Association between stroke and acute myocardial infarction and its related risk factors: hypertension and diabetes. Anadolu Kardiyol Derg. 2005; 5: 24-7

(4)

58 Japanese population: the Hisayama Study. Cardiovascular Diabetology. 2013, 12:164

23. Doi Y, Ninomiya T, Hata J, et al. Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: the Hisayama Study. Stroke. 2010, 41:203–209.

24. Shuangxi G, Song T, Bo S. Study of the relationship of glycated hemoglobin levels and neurological impairment and three monthsprognosis in patients with acute ischemic stroke. Life Science Journal, 2012;9(2)

25. Oh HG, Rhee EJ, Kim TW, et al. Higher Glycated Hemoglobin Level Is Associated with Increased Risk for Ischemic Stroke in Non-Diabetic Korean Male Adults. Diabetes Metab J. 2011;35:551-557

26. Selvin E, Coresh J, Shahar E, et al. Glycaemia (haemoglobinA1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Lancet Neurol 2005; 4: 821-6.

27. Zafar A, Shahid SK, Siddiqui M, Khan FS. Pattern of stroke in type 2 diabetic subjects versus non diabetic subjects. J Ayub Med Coll Abbottabad. 2007;19(4): 64-67

(5)

59 29. Haque KS, Siddiqui MR. Clinical Significance of Glycated Hemoglobin

(HbA1c).AKMMC J. 2013; 4(1): 3-5

30. World Health Organization. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. Abbreviated Report of a WHO Consultation. Geneva. WHO. 2011

31. Braatvedt GD, Cundy T, Crooke M, Florkowski C, Mann JI, Lunt H, et al. Understanding the new HbA1c units for the diagnosis of Type 2 diabetes. N Z Med J 2012;125:70-80.

32. Pani LN, Korenda L, Meigs JB, et al. Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham. Diabetes Care 2008 Oct;31(10):1991-6. Epub 2008

33. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011;34 (Suppl 1): 62-9.

34. NHS/Diabetes UK, HbA1c Standardisation For Laboratory Professionals" . Diabetes UK.

35. Consensus statement on the worldwide standardisation of the HbA1c measurement. Diabetologia 2007; 50: 2042–3

36. Mbanya J. The standardization of glycated haemoglobin: Is it desirable?. Diabetes Voice. 2005; 50(2): 27-30.

(6)

60 38. Dods R.F, Diabetes Mellitus, In Clinical Chemistry: Theory, Analysis,

Correlation, Eds, Kaplan L.A, Pesce A.J, 3rd Edition, Mosby Inc, USA, 1996:613-640

39. Sacks D.B., Carbohydrates, In Tietz Fundamentals of Clinical Chemistry, Eds Burtis C.A, Ashwood E.R, 5th Edition, W.B. Saunders Company, USA, 2001:427-461

40. King, M.E., Glycosylated Hemoglobin, In Method’s in Clinical Chemistry, Eds Amadeo J, Kaplan L.A., 1987:113-116

41. Peterson K.P., Pavlovich J.G., Goldstein D., et al., What is Hemoglobin A1c? An Analysis of Glycated Hemoglobins by Electrospray Ioni-zation Mass Spectrometry, Clinical Chemistry, 44:9, 1998:1951-1958

42. Chandalia HB, Krishnaswamy PR. Glycated Hemoglobin. Current Science;2002; 83(12): 1522-32.

43. Sakurabayashi I, Watano T, Yonehara S, Ishimaru K, et al. New Enzymatic Assay for Glycohemoglobin. Clin Chemis. 2003; 49(2): 269-74

44. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab. 2008;93 (7): 2447-2453

45. Bonora E, Tuomilehto J. The pros and cons of diagnosing diabetes with A1C. Diabetes Care. 2011; 34: S184–S190.

(7)

61 Prediabetes and Metabolic Syndrome. Can J Diabetes 37 (2013). S8-S11

47. The expert committee on the diagnosis and classification of diabetes mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes care, volume 25, supplement 1, january 2002.

48. Suyono S, Sudoyo A, Setiyohadi B, Alwi I, Setiati S, Simadibrat M, et al. Diabetes Melitus Indonesia. Jakarta: IPD FKUI; 2007. Hal.1852-7. 49. International Diabetes Federation. Diabetes Atlas. 6th ed. Brussels

(Belgium): International Diabetes Federation; 2013

50. Harrison LC, Wentworth JM, Elkassaby S, Fourlanos S and Greenbaum CJ. Reappraising the Stereotypes of Diabetes. In: Greenbaum CJ, Harrison LC.ed. Diabetes: Translating Researchinto Practice Informa Healthcare USA. 2008

51. Laakso M. Epidemiology of Type 2 Diabetes. In: Goldstein BJ, Müller-Wieland D.ed. Type 2 Diabetes Principles and Practice.2nd Ed. Informa Healthcare USA.2008

(8)

62 53. Basu S, Sanyal D, Roy K, Bhattacharya KB. Is post-stroke hyperglycemia a marker of stroke severity and prognosis: A pilot study. Neurology Asia. 2007; 12 : 13 – 19

54. WHO Consultation. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications.Part 1: Diagnosis and Classification of Diabetes Mellitus. Report No 99.2. Geneva. WHO. 1999

55. Price SA & Wilson LM. Patofisiologi. Konsep Klinis Proses-Proses Penyakit jilid 2. EGC. Jakarta. 2006: 1110-19

56. Stumvol IM, Goldstein BJ, Haeften TW. Pathogenesis of Type 2 Diabetes. In: Goldstein BJ, Müller-Wieland D.ed. Type 2 Diabetes Principles and Practice.2nd Ed. Informa Healthcare USA.2008

57. Guyton, C.A., Hall, J.E. Texbook of Medical Physiology.(9th Ed). Philadelphia: W.B Saunders Company.2007

58. Waspadji, S. Komplikasi Kronik Diabetes: Mekanisme terjadinya, Diagnosis dan Strategi Pengelolaan. Metabolik Endokrin. Buku Ajar Penyakit Dalam. Pusat Penerbitan Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Indonesia. Jakarta.2006

59. Gilman S. Advances in neurology. N Engl J Med. 1992; 326: 1671-6. 60. Sjahrir, H., 2003. Stroke Iskemik. Medan: Yandira Agung.

(9)

63 62. Madiyono B & Suherman SK. Pencegahan Stroke & Serangan Jantung

Pada Usia Muda. Balai Penerbit FKUI. Jakarta. 2003.hal:3-11

63. Japardi, I . Patogenesis Stroke Iskemik Tromboemboli. 2002 digitized by USU digital library.

Available from ; http://librar y.usu.ac.id/download/fk/bedah.pdf.

64. Albers GW, Hart RG, Lutsep HL, Newell DW, Sacco RL. Supplement to the Guidelines for the Management of Transient Ischemic Attacks. A Statement From the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks, Stroke Council, American Heart Association. Stroke. 1999;30:2502-2511.

diakses 20 februari 2014

65. National Stroke Foundation. Clinical Guidelines for Stroke Management 2010. Melbourne Australia.

66. Mardjono M & Sidharta P. Neurologi Klinis Dasar. Penerbit Dian Rakyat. Jakarta. 2010: 290-91.

67. Wahjoepramono, Eka J. Stroke Tata Laksana Fase Akut. Jakarta: Universitas Pelita Harapan.2005

68. Silverman IE, Rymer MM. Ischemic stroke. An Atlas of Investigation and Treatment. Atlas Medical Publishing. USA. 2009

69. Starn J. Trombosis of Cerebral Vein and Sinuses. N Engl J Med. 2005; 352:1791-8

(10)

64 71. Hinkle JL, Guanci MMK. Acute Ischemic Stroke Review. J Neurosci

Nurs. 2007; 39:285-293, 310

72. Woodruff TM, Thundyil J, Tang SC, Sobey CG, Taylor SM. Pathophysiology, treatment, animal and cellular models of human ischemic stroke. Molecular Neurodegeneration. 2011; 6:11

73. Maas, MB. Safdieh, JE. Ischemic Stroke: Pathophysiology and Principles of Localization. Neurology Board Review Manual. Neurology. 2009; 13(1): 2-16

74. Loho T. Pemeriksan Laboratorium pada stroke dalam Pendidikan Berkesinambungan Patologi Klinik, Ed 1, Penerbit FK UI. 2008. p: 57-70

75. Browaeys P, Binaghi S, Meuli RA. Multislice computed tomography in scute stroke. In: Knollmann F, Coakley FV, sditors. Multislice CT: principles and protocols. Philadelphia: Saunders Elsevier 2006. p: 1-16 76. Wintemark M, Reichhart M, Cuisenaire O. Comparison of admission

perfusion computed tomography and qualitative difussion and perfusion-weighted magnetic resonance imaging in acute stroke patients. Stroke. 2002. p: 2025-31

77. Rassmussen D et al. Computed Tomography in Prognostic Stroke Evaluation. 1992; P: 506-10

Referensi

Dokumen terkait

The results from our previous studies indicate that Dx value is relatively proportional to the earthquake magnitude (Akhoondzadeh, 2011). The earthquake magnitude

Keuntungan (kerugian) aktuarial program imbalan pasti g. Pajak penghasilan terkait dengan penghasilan komprehensif lain h. Selisih kuasi reorganisasi 4).. 21. Selisih

Program Frontpage XP merupakan Editor dari HTML (Hyper Text Markup Language) yang juga dasar dari pembuatan Website ini, didalam Html terdapat berbagai macam tag-tag dan atribut

Dengan membuat suatu aplikasi pembelajan doa seharihari menggunakan Macromedia Flash MX, diharapkan dapat memberikan banyak tampilan-tampilan gambar yang menarik Penulisan ini

[r]

Software yang penulis gunakan dalam pembuatan website ini ialah Macromedia DREAMWEAVER 8 sebagai editor yang menggabungkan antara desain dan pemograman web menjadi satu, serta PHP

ini  diminta  kepada  seluruh  Kepala  SKPO  dan  UKPO  dilingkungan  Provinsi  OKI . Jakarta,  membuat  laporan  daftar  nama  pegawai  di  unit  saudara 

Undang-Undang Nomor 36 Tahun 2009 tentang Kesehatan menyebutkan bahwa praktik kefarmasian meliputi pembuatan termasuk pengendalian mutu Sediaan Farmasi, pengamanan, pengadaan,